SHAREHOLDER ALERT: Investigation of AxoGen Announced by Holzer & Holzer, LLC

ATLANTA--()--Holzer & Holzer, LLC is investigating whether certain statements made by AxoGen, Inc. (“AxoGen” or the “Company”) (NASDAQ: AXGN) complied with federal securities laws. On December 18, 2018, Seligman Investments issued a report raising questions about the accuracy of AxoGen’s descriptions of the Company’s operations and sales. The price of AxoGen stock fell significantly following the report.

If you purchased AxoGen securities and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Marshall P. Dees, Esq. at mdees@holzerlaw.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

Contacts

Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com

Release Summary

Holzer investigates AxoGen

Contacts

Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com